Home LiteratureArticle Details
PMID: 8027173 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

The types II and III transforming growth factor-beta receptors form homo-oligomers.

The Journal of cell biology ·Vol. 126 ·No. 1 ·1994-07-00 ·Pages 139-54

Henis YI, Moustakas A, Lin HY, Lodish HF

Abstract

Affinity-labeling experiments have detected hetero-oligomers of the types I, II, and III transforming growth factor beta (TGF-beta) receptors which mediate intracellular signaling by TGF-beta, but the oligomeric state of the individual receptor types remains unknown. Here we use two types of experiments to show that a major portion of the receptor types II and III forms homo-oligomers both in the absence and presence of TGF-beta. Both experiments used COS-7 cells co-transfected with combinations of these receptors carrying different epitope tags at their extracellular termini. In immunoprecipitation experiments, radiolabeled TGF-beta was bound and cross-linked to cells co-expressing two differently tagged type II receptors. Sequential immunoprecipitations using anti-epitope monoclonal antibodies showed that type II TGF-beta receptors form homo-oligomers. In cells co-expressing epitope-tagged types II and III receptors, a low level of co-precipitation of the ligand-labeled receptors was observed, indicating that some hetero-oligomers of the types II and III receptors exist in the presence of ligand. Antibody-mediated cross-linking studies based on double-labeling immunofluorescence explored co-patching of the receptors at the cell surface on live cells. In cells co-expressing two differently tagged type II receptors or two differently tagged type III receptors, forcing one receptor into micropatches by IgG induced co-patching of the receptor carrying the other tag, labeled by noncross-linking monovalent Fab'. These studies showed that homo-oligomers of the types II and III receptors exist on the cell surface in the absence or presence of TGF-beta 1 or -beta 2. In cells co-expressing types II and III receptors, the amount of heterocomplexes at the cell surface was too low to be detected in the immunofluorescence co-patching experiments, confirming that hetero-oligomers of the types II and III receptors are minor and probably transient species.

MeSH Terms
Affinity Labels Animals Cell Compartmentation Cell Membrane/chemistry,metabolism Cells, Cultured Chlorocebus aethiops Fluorescent Antibody Technique Models, Biological Precipitin Tests Protein Conformation Protein Serine-Threonine Kinases Proteoglycans Receptor, Transforming Growth Factor-beta Type II Receptors, Transforming Growth Factor beta/chemistry,classification,genetics,metabolism Recombinant Proteins/chemistry,classification,metabolism Transfection Transforming Growth Factor beta/metabolism
Chemicals
Affinity Labels Proteoglycans Receptors, Transforming Growth Factor beta Recombinant Proteins Transforming Growth Factor beta betaglycan Protein Serine-Threonine Kinases Receptor, Transforming Growth Factor-beta Type II
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Henis Y I
Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142.
Moustakas A
Lin H Y
Lodish H F
References (55)
55 references, click to expand
  1. Cloning and sequencing of a rat type II activin receptor.
    FEBS Lett. 1992 Nov 2;312(1):53-6 PMID: 1385212
  2. Characterization of transforming growth factor-beta (TGF-beta) receptors on BeWo choriocarcinoma cells including the identification of a novel 38-kDa TGF-beta binding glycoprotein.
    Mol Biol Cell. 1992 Nov;3(11):1295-307 PMID: 1333844
  3. Transforming growth factor-beta inhibition of epithelial cell proliferation linked to the expression of a 53-kDa membrane receptor.
    J Biol Chem. 1989 Feb 5;264(4):2272-8 PMID: 2536702
  4. Preparation of F(ab')2 fragments from monoclonal mouse IgG1 suitable for use in radioimaging.
    J Immunol Methods. 1988 Jun 13;110(2):229-36 PMID: 3132507
  5. daf-1, a C. elegans gene controlling dauer larva development, encodes a novel receptor protein kinase.
    Cell. 1990 May 18;61(4):635-45 PMID: 2160853
  6. The transforming growth factor beta receptors types I, II, and III form hetero-oligomeric complexes in the presence of ligand.
    J Biol Chem. 1993 Oct 25;268(30):22215-8 PMID: 7693660
  7. Transforming growth factor-beta (TGF-beta)-resistant helper T lymphocyte clones show a concomitant loss of all three types of TGF-beta receptors.
    J Immunol. 1991 May 1;146(9):3063-7 PMID: 1849940
  8. Cloning and characterization of a transmembrane serine kinase that acts as an activin type I receptor.
    Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11242-6 PMID: 8248234
  9. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product.
    Mol Cell Biol. 1985 Dec;5(12):3610-6 PMID: 3915782
  10. Rapid and efficient site-specific mutagenesis without phenotypic selection.
    Methods Enzymol. 1987;154:367-82 PMID: 3323813
  11. Signaling activity of transforming growth factor beta type II receptors lacking specific domains in the cytoplasmic region.
    Mol Cell Biol. 1993 Dec;13(12):7239-47 PMID: 8246946
  12. Responsiveness to transforming growth factor-beta (TGF-beta) restored by genetic complementation between cells defective in TGF-beta receptors I and II.
    J Biol Chem. 1991 May 15;266(14):9108-12 PMID: 1851167
  13. Cloning of a second type of activin receptor and functional characterization in Xenopus embryos.
    Science. 1992 Mar 27;255(5052):1702-5 PMID: 1313188
  14. Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor.
    Science. 1993 May 28;260(5112):1344-8 PMID: 8388127
  15. Receptors for the TGF-beta superfamily: multiple polypeptides and serine/threonine kinases.
    Trends Cell Biol. 1993 Jan;3(1):14-9 PMID: 14731534
  16. Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta.
    J Cell Biol. 1989 Dec;109(6 Pt 1):3137-45 PMID: 2592419
  17. A widely expressed transmembrane serine/threonine kinase that does not bind activin, inhibin, transforming growth factor beta, or bone morphogenic factor.
    J Biol Chem. 1993 Jun 15;268(17):12719-23 PMID: 8389764
  18. Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity.
    Oncogene. 1993 Oct;8(10):2879-87 PMID: 8397373
  19. The transforming growth factor-beta system, a complex pattern of cross-reactive ligands and receptors.
    Cell. 1987 Feb 13;48(3):409-15 PMID: 2879635
  20. Binding of transforming growth factor-beta to cell surface proteins varies with cell type.
    Mol Endocrinol. 1989 Feb;3(2):261-72 PMID: 2710133
  21. Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells.
    J Biol Chem. 1990 May 25;265(15):8361-4 PMID: 1692830
  22. Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors.
    Cell. 1993 Nov 19;75(4):671-80 PMID: 8242742
  23. Absence of TGF-beta receptors and growth inhibitory responses in retinoblastoma cells.
    Science. 1988 Apr 8;240(4849):196-9 PMID: 2895499
  24. Growth inhibition by transforming growth factor beta (TGF-beta) type I is restored in TGF-beta-resistant hepatoma cells after expression of TGF-beta receptor type II cDNA.
    Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5359-63 PMID: 8389483
  25. Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure.
    Proc Natl Acad Sci U S A. 1987 May;84(10):3365-9 PMID: 2437578
  26. Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase.
    Cell. 1992 Feb 21;68(4):775-85 PMID: 1310899
  27. Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system.
    Cell. 1991 Nov 15;67(4):785-95 PMID: 1657406
  28. Inhibition of growth by transforming growth factor-beta following fusion of two nonresponsive human carcinoma cell lines. Implication of the type II receptor in growth inhibitory responses.
    J Biol Chem. 1992 Feb 5;267(4):2588-93 PMID: 1370826
  29. A dominant-negative receptor for type beta transforming growth factors created by deletion of the kinase domain.
    J Biol Chem. 1993 Jun 5;268(16):11500-3 PMID: 8389353
  30. Sendai virus envelope glycoproteins become laterally mobile on the surface of human erythrocytes following fusion.
    Exp Cell Res. 1985 Oct;160(2):514-26 PMID: 2995100
  31. Molecular characterization of rat transforming growth factor-beta type II receptor.
    Biochem Biophys Res Commun. 1993 Mar 31;191(3):790-5 PMID: 8385453
  32. Epitope tagging and protein surveillance.
    Methods Enzymol. 1991;194:508-19 PMID: 1706460
  33. Novel activin receptors: distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors.
    Cell. 1992 Jan 10;68(1):97-108 PMID: 1310075
  34. Molecular cloning and characterization of a novel rat activin receptor.
    Biochem Biophys Res Commun. 1992 Mar 16;183(2):672-9 PMID: 1312838
  35. TGF beta signals through a heteromeric protein kinase receptor complex.
    Cell. 1992 Dec 11;71(6):1003-14 PMID: 1333888
  36. Expression cloning of an activin receptor, a predicted transmembrane serine kinase.
    Cell. 1991 Jun 14;65(6):973-82 PMID: 1646080
  37. A transforming growth factor beta type I receptor that signals to activate gene expression.
    Science. 1994 Jan 7;263(5143):87-9 PMID: 8272871
  38. Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor-beta type II receptor family.
    Dev Dyn. 1993 Feb;196(2):133-42 PMID: 8395914
  39. The structure of an antigenic determinant in a protein.
    Cell. 1984 Jul;37(3):767-78 PMID: 6204768
  40. Determination of type I receptor specificity by the type II receptors for TGF-beta or activin.
    Science. 1993 Nov 5;262(5135):900-2 PMID: 8235612
  41. TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights.
    Cell. 1990 Oct 19;63(2):245-7 PMID: 2208284
  42. Identification of a Drosophila activin receptor.
    Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9475-9 PMID: 8415726
  43. A truncated activin receptor inhibits mesoderm induction and formation of axial structures in Xenopus embryos.
    Nature. 1992 Oct 15;359(6396):609-14 PMID: 1328888
  44. The daf-4 gene encodes a bone morphogenetic protein receptor controlling C. elegans dauer larva development.
    Nature. 1993 Oct 14;365(6447):644-9 PMID: 8413626
  45. Oligomeric structure of the human asialoglycoprotein receptor: nature and stoichiometry of mutual complexes containing H1 and H2 polypeptides assessed by fluorescence photobleaching recovery.
    J Cell Biol. 1990 Oct;111(4):1409-18 PMID: 2211817
  46. Molecular cloning and characterization of the human and porcine transforming growth factor-beta type III receptors.
    Biochem Biophys Res Commun. 1992 Nov 30;189(1):356-62 PMID: 1333192
  47. Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor.
    Cell. 1993 Nov 19;75(4):681-92 PMID: 8242743
  48. Two forms of transforming growth factor-beta distinguished by multipotential haematopoietic progenitor cells.
    Nature. 1987 Oct 8-14;329(6139):539-41 PMID: 2889143
  49. Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-beta activities.
    Science. 1993 May 28;260(5112):1335-8 PMID: 8388126
  50. Expression cloning and characterization of the TGF-beta type III receptor.
    Cell. 1991 Nov 15;67(4):797-805 PMID: 1657407
  51. Lateral diffusion of proteins in membranes.
    Annu Rev Physiol. 1987;49:163-75 PMID: 3551795
  52. Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells.
    J Biol Chem. 1992 Sep 25;267(27):19027-30 PMID: 1326540
  53. Multiple genes for Xenopus activin receptor expressed during early embryogenesis.
    FEBS Lett. 1992 May 25;303(1):81-4 PMID: 1317302
  54. Concomitant loss of transforming growth factor (TGF)-beta receptor types I and II in TGF-beta-resistant cell mutants implicates both receptor types in signal transduction.
    J Biol Chem. 1990 Oct 25;265(30):18518-24 PMID: 2170414
  55. Betaglycan presents ligand to the TGF beta signaling receptor.
    Cell. 1993 Jul 2;73(7):1435-44 PMID: 8391934
Article Info
Journal
The Journal of cell biology
Abbr.
J Cell Biol
ISSN
0021-9525
Published
1994-07-00
Pages
139-54
Language
English
Region
United States
NLM ID
0375356
PMCID
PMC2120107
Subset
IM
Grants
NHLBI NIH HHS · HL 41484 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com